To purchase hard copies of this book, please email:
orders@intechopen.com
By only printing on demand InTech ensures our carbon footprint is kept to a minimum.
The data below shows the environmental impact of printing one single book:
66.38 kg wood
3.57 g CO2
60.27 ml Water
Share this page
Bladder Cancer - From Basic Science to Robotic Surgery
Edited by Abdullah Erdem Canda, ISBN 978-953-307-839-7, Hard cover, 460 pages, Publisher: InTech, Published: February 01, 2012 under CC BY 3.0 license, in subject Oncology
DOI: 10.5772/1069
This book is an invaluable source of knowledge on bladder cancer biology, epidemiology, biomarkers, prognostic factors, and clinical presentation and diagnosis. It is also rich with plenty of up-to-date information, in a well-organized and easy to use format, focusing on the treatment of bladder cancer including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy. These chapters, written by the experts in their fields, include many interesting, demonstrative and colorful pictures, figures, illustrations and tables. Due to its practicality, this book is recommended reading to anyone interested in bladder cancer.
This book is indexed in:
Book contents
- Chapter 1Bladder Cancer Biology
- Chapter 2Biomarkers of Bladder Cancer in Urine: Evaluation of Diagnostic and Prognostic Significance of Current and Potential Markers
- Chapter 3Epigenetic Biomarkers in Bladder Cancer
- Chapter 4Angiogenesis, Lymphangiogenesis and Lymphovascular Invasion: Prognostic Impact for Bladder Cancer Patients
- Chapter 5Angiogenesis and Lymphangiogenesis in Bladder Cancer
- Chapter 6UHRF1 is a Potential Molecular Marker for Diagnosis and Prognosis of Bladder Cancer
- Chapter 7Epidemiology and Polymorphisms Related to Bladder Cancer in Ecuadorian Individuals
- Chapter 8Clinical Presentation
- Chapter 9Role of HPV in Urothelial Carcinogenesis: Current State of the Problem
- Chapter 10Bladder Cancer and Schistosomiasis: Is There a Difference for the Association?
- Chapter 11Hemocyanins in the Immunotherapy of Superficial Bladder Cancer
- Chapter 12The Potential Role of Chemoprevention in the Management of Non-Muscle Invasive Bladder Urothelial Carcinoma
- Chapter 13The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells
- Chapter 14Chemotherapy for Metastatic Disease
- Chapter 15Robot-Assisted Radical Cystectomy as a Treatment Modality for Patients with Muscle-Invasive Bladder Cancer
- Chapter 16Robotic-Assisted Laparoscopic Radical Cystoprostatectomy and Intracorporeal Urinary Diversion (Studer Pouch or Ileal Conduit) for Bladder Cancer
- Chapter 17Current Trends in Urinary Diversion in Men
- Chapter 18The H19-IGF2 Role in Bladder Cancer Biology and DNA-Based Therapy
- Chapter 19Animal Models for Basic and Preclinical Research in Bladder Cancer
- Chapter 20Intracellular Arsenic Speciation and Quantification in Human Urothelial and Hepatic Cells
- Chapter 21Chemoprevention and Novel Treatments of Non-Muscle Invasive Bladder Cancer
